Please try another search
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include human albumin; intravenous human immunoglobulin; tetanus human immunoglobulin; rabies patient immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; and human prothrombin complex blood products. The company was founded in 1919 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. is a subsidiary of China National Biotec Group Company Limited.
Name | Age | Since | Title |
---|---|---|---|
Cui Yulin | - | - | Director |
Daoxing Fu | 57 | 2017 | MD & Director |
Huichuan Yang | 54 | 2016 | Director |
Xiaoming Yang | 59 | 2015 | Chairman |
Ligang Hu | 47 | 2015 | Director |
Xiangrong Li | 51 | 2018 | Director |
Li Gang Hu | 48 | 2020 | Director |
Hui Chuan Yang | 54 | 2014 | Chairman of the Board |
Dao Xing Fu | 58 | 2020 | GM & Director |
Fenling Gu | 60 | 2020 | Independent Director |
Yanlin He | 56 | - | Deputy GM & Director |
Yan Fang | 55 | 2020 | Independent Director |
Jianming Wang | 52 | 2020 | Employee Supervisor |
Yana Liu | 48 | 2020 | Deputy GM & Director |
Tan Cheng | 45 | 2022 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review